Titelia

Funds holding PASITHEA THERAPEUTICS CORP

ISIN US70261F2020 · United States

Fund holders
4
Of which ETFs
1 3 other funds
Value held
334K $
Share of capital
1.3 % of 33.4M shares on Aug 12, 2026
FundSharesValueWeight in fundShare of capital
AdvisorShares Psychedelics ETF AdvisorShares Trust 337,508250.4K $1.24 %1.01 %as of Mar 31, 2026
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS 53,81539.9K $0.16 %as of Mar 31, 2026
Fidelity Extended Market Index Fund Fidelity Concord Street Trust 41,60836.7K $0.00 %0.12 %as of Feb 28, 2026
Fidelity Series Total Market Index Fund Fidelity Concord Street Trust 7,9697K $0.02 %as of Feb 28, 2026

Download this table: CSV, JSON

Report an error

The funds most exposed to it

The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.

FundWeight in fund
AdvisorShares Psychedelics ETF AdvisorShares Trust 1.24 %as of Mar 31, 2026
Fidelity Extended Market Index Fund Fidelity Concord Street Trust 0.00 %as of Feb 28, 2026

Quarter after quarter

Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.

QuarterHoldersChangeSharesChange
2026Q240440,900+15.7 %
2026Q140381,219+16.3 %
2025Q44+1327,845+62.0 %
2025Q330202,318+252.5 %
2025Q23+157,391+1,393.0 %
2025Q1203,844-28.4 %
2024Q4205,372-15.7 %
2024Q3206,371-0.8 %
2024Q226,420

Institutional managers

19 managers declare this company to the SEC (Form 13F).

ManagerSharesValue
JANUS HENDERSON GROUP PLC2,100,0001.6M $as of Mar 31, 2026
Vivo Capital, LLC2,100,0001.6M $as of Mar 31, 2026
Squadron Capital Management LLC2,100,0001.6M $as of Mar 31, 2026
ADAGE CAPITAL PARTNERS GP, L.L.C.2,100,0001.6M $as of Mar 31, 2026
AMERIPRISE FINANCIAL INC1,350,8961M $as of Mar 31, 2026
Cable Car Capital, LP1,206,379894.9K $as of Mar 31, 2026
Stonepine Capital Management, LLC831,301616.7K $as of Mar 31, 2026
AdvisorShares Investments LLC337,508250.4K $as of Mar 31, 2026
Persistent Asset Partners Ltd290,555215.5K $as of Mar 31, 2026
GEODE CAPITAL MANAGEMENT, LLC103,98577.1K $as of Mar 31, 2026
RENAISSANCE TECHNOLOGIES LLC93,39969.3K $as of Mar 31, 2026
XTX Topco Ltd33,75125K $as of Mar 31, 2026
UBS Group AG26,14919.4K $as of Mar 31, 2026
TWO SIGMA INVESTMENTS, LP21,05415.6K $as of Mar 31, 2026
NORTHERN TRUST CORP19,37214.4K $as of Mar 31, 2026
Hurley Capital, LLC3,6892.7K $as of Mar 31, 2026
Tower Research Capital LLC (TRC)1,8541.4K $as of Mar 31, 2026
SBI Securities Co., Ltd.1,051780 $as of Mar 31, 2026
JPMORGAN CHASE & CO150107 $as of Mar 31, 2026

Declared shareholders of PASITHEA THERAPEUTICS CORP

There are 4 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.

ShareholderDeclared stakeShares
Opaleye Management Inc. and 2 others9.99 %2,491,000as of Apr 1, 2026 · SCHEDULE 13G
Funicular Funds, LP and 2 others7.40 %1,839,512as of Apr 15, 2026 · SCHEDULE 13G
Stonepine Capital Management, LLC and 3 others5.80 %1,952,550as of Jun 17, 2026 · SCHEDULE 13G
Ameriprise Financial, Inc. and 1 other5.40 %1,350,896as of Mar 31, 2026 · SCHEDULE 13G
Cite this page

Titelia. "Funds holding PASITHEA THERAPEUTICS CORP". https://titelia.com/en/stocks/pasithea-therapeutics-corp-US70261F2020